GPC3-CAR-T Cells for the Hepatocellular Carcinoma

Clinical trial NCT04506983 · SUSPENDED

Trial details

NCT number: NCT04506983
Sponsor: Beijing Tsinghua Chang Gung Hospital
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2022-06-10
Primary completion: 2023-06-10
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.